Skip to content
healthcare.dev

Caffeine and Sodium Benzoate

NDC 0517-2502, Caffeine and Sodium Benzoate, injection, solution, from American Regent, Inc..

Product NDC
0517-2502
Status
Listed
Labeler
American Regent, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0517-2502 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAFFEINE125 mg/mL

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
0517-2502-100051725021010 VIAL, SINGLE-DOSE in 1 BOX (0517-2502-10) / 2 mL in 1 VIAL, SINGLE-DOSE (0517-2502-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b2c6b352-f837-4903-8e4c-fb0a2b20bb60

Use it

Look up 0517-2502 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0517-2502 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0517-2502. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.